Evidence map›Paper›PMID 40387600›Full record

ArticleCancer research2025

Adaptation to Volumetric Compression Drives an Apoptosis-Resistant and Invasive Phenotype in Liver Cancer.

Xiangyu Gong, Noriyoshi Ogino, M Fátima Leite, Dingyao Zhang, Zehua Chen, Ryan Y Nguyen, Raymond Liu, Emma Kruglov, Kaitlin Flores, Aidan T Cabral and 3 more

Abstract read
In one paragraph

Article in Cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Xiangyu GongDepartment of Pharmacological Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York.ORCID 0000-0003-4033-9570
Noriyoshi OginoYale Liver Center, Yale University School of Medicine, New Haven, Connecticut.ORCID 0000-0002-1877-7577
M Fátima LeiteDepartment of Physiology and Biophysics, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.ORCID 0000-0001-9709-8865
Dingyao ZhangDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut.ORCID 0000-0001-9273-7824
Zehua ChenDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.ORCID 0000-0001-6235-9770
Ryan Y NguyenDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.ORCID 0000-0002-5001-7893
Raymond LiuDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut.ORCID 0000-0003-4102-8352
Emma KruglovDepartment of Internal Medicine, Yale University, New Haven, Connecticut.ORCID 0009-0005-9867-8016
Kaitlin FloresDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.ORCID 0000-0002-4746-9565
Aidan T CabralDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.ORCID 0009-0000-3422-1758
Gabriel Moreira de M MendesFaculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.ORCID 0000-0003-1427-8401
Barbara E EhrlichYale Liver Center, Yale University School of Medicine, New Haven, Connecticut.ORCID 0000-0001-9657-9704
Michael MakDepartment of Pharmacological Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York.ORCID 0000-0001-6881-8130

Funding

Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI WAJAHAT Zafar MEHAL · 1986 to 2026
$31.1M
TRANSFER GRANT: Systems Biophysics of Multiscale State Transitions in Cells and TissuesR35GM142875 · NIGMS · YALE UNIVERSITY · PI Michael MAK · 2021 to 2026
$2.7M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysisS10OD030363 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2022 to 2022
$1.2M
Convergent Graduate Training in Engineering, Physics and BiologyT32EB019941 · NIBIB · YALE UNIVERSITY · PI O'HERN, COREY · 2016 to 2020
$998k
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)National Institutes of Health (NIH) NIH P30 DK034989National Institutes of Health (NIH) NIH R35GM142875National Institutes of Health (NIH) NIH T32EB019941NIBIB NIH HHS T32 EB019941NIDDK NIH HHS P30 DK034989NIGMS NIH HHS R35 GM142875NIH HHS S10 OD030363
6 · The paper itself

Abstract

Physical constraints like compression influence cancer cell invasion and transcriptional dynamics in various tumors. Liver cancer is characterized by the rapid proliferation of tumor cells within a densely packed tissue matrix, subjecting the cancer cells to crowding and compression. The highly dysregulated mechanical environment highlights the need to elucidate the broader impact of compression on liver cancer development and evolution. In this study, we investigated and described a unique adaptive response of liver cells to prolonged compression. Liver cells presented significant transcriptional changes due to compression, including the loss of liver-specific markers and enrichment of epithelial-to-mesenchymal transition genes. Compression elevated Rac1 activity, which promoted cellular protrusions and YAP nuclear translocation and maintained cell viability under mechanical stress. Furthermore, compression disrupted intracellular calcium signaling, leading to resistance to apoptosis. Counteracting the effects of compression by inhibiting Rac1 or manipulating intracellular calcium facilitated death of compression-adapted cells. This study highlights compression as a critical biophysical signal in the tissue microenvironment that can induce cell state transitions and disease-driving phenotypes in the liver. SIGNIFICANCE: Compression in liver cancer affects cell states, signaling, and survival, which can be counteracted by inhibiting Rac1 or targeting intracellular calcium as potential avenues to eradicate compression-induced aggressive cancer cells.

Indexed as

ApoptosisLiver NeoplasmsCalciumCalcium SignalingCell Line, TumorEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansNeoplasm InvasivenessPhenotyperac1 GTP-Binding ProteinStress, MechanicalTumor MicroenvironmentCalciumrac1 GTP-Binding ProteinRAC1 protein, human

Identifiers

PMID40387600
PMCPMC12354003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.